Share This Article

Facebook LinkedIn
Twitter Reddit
Print Email
Pinterest Gmail
Yahoo
Money Morning
×
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • Angel Investing
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
  • Retire
    • Income Investing Guide
    • Retirement Articles
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
Login My Member Benefits Archives Research Your Team About Us FAQ
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • Angel Investing
    ×
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
    ×
  • Retire
    • Income Investing Guide
    • Retirement Articles
    ×
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    ×
  • Subscribe
Enter stock ticker or keyword
×
5 Ways to Beat the Fed (and Crush Inflation)

Email this Article

Send with mail | ahoo instead.
Required Needs to be a valid email
Required Needs to be a valid email
Top Penny Stock Gainers to Watch in August 2017
https://mney.co/2uTpWVm
Required Please enter the correct value.
Twitter
Stocks: ACRX, AEZS, DARE, OSUR, VSTM

Top Penny Stock Gainers to Watch in August 2017

By Alex McGuire, Associate Editor, Money Morning • @AlexMcGuire92 • July 25, 2017

View Comments

Start the conversation

Comment on This Story Click here to cancel reply.

Or to contact Money Morning Customer Service, click here.

Your email address will not be published. Required fields are marked *

Some HTML is OK

The list below shows the 10 top penny stock gainers to watch in August 2017, based on the top performers of July 2017. And after the chart, we'll show you one of the best small-cap stocks to invest in this year...

Penny Stock Current Stock Price July 2017 Return (as of July 24)
Daré Bioscience Inc. (Nasdaq: DARE) $5.06 +1,039.6%
Aeterna Zentaris Inc. (Nasdaq: AEZS) $2.30 +130%
AcelRx Pharmaceuticals Inc. (Nasdaq: ACRX) $3.65 +69.8%
TearLab Corp. (Nasdaq: TEAR) $2.83 +69.5%
Verastem Inc. (Nasdaq: VSTM) $3.67 +68.3%
Sito Mobile Ltd. (Nasdaq: SITO) $6.01 +62%
XG Technology Inc. (Nasdaq: XGTI) $2.54 +55.8%
Monster Digital Inc. (Nasdaq: MSDI) $0.75 +54.2%
Bon-Ton Stores Inc. (Nasdaq: BONT) $0.65 +48.6%
Capricor Therapeutics Inc. (Nasdaq: CAPR) $1.12 +35%

The top penny stock of July 2017 is Daré Bioscience, which has exploded 1,039.6% this month and soared 809% on July 20 alone, when it rose from $0.66 to $6 per share. DARE's quadruple-digit return this month comes after the firm completed a merger with cancer drug developer Cerulean Pharma Inc. (Nasdaq: CERU)...

penny stock gainers to watch in august 2017Back in March, Cerulean agreed to sell itself to Daré for $7.5 million and lay off 11 of the 19 Cerulean employees. The deal finally closed on July 20, and the newly combined company will retain the name Daré Biosciences Inc. and the ticker DARE.

Anyone who owned shares of DARE stock before market close on July 19 became owners of approximately 51% of outstanding Cerulean shares. This news significantly spiked demand for DARE stock, sending it up a stunning 809% from $0.66 to $6 on July 20.

But while the 1,039.6% gain earned by DARE stock this month may be attractive, we don't advise investing in that or any of the other penny stock gainers listed above. Since they've already seen gains in July, August might not be the best time to buy them. They might already be trading at inflated prices.

Buying penny stocks like these that have been ripping higher all month can be risky for investors who haven't done their homework. When looking for profitable penny stocks, conducting research into 10-K documents - which outline a firm's annual revenue, profits, and executive compensation - and quarterly earnings reports is crucial to making sure they're legitimate and profitable.

Trending: Five Pharmaceutical Penny Stocks to Watch for August 2017

But Money Morning Small-Cap Specialist Sid Riggs prefers to do the intensive research for you...

Although many of his small-cap recommendations cost slightly more than the typical penny stock cutoff of $5, they cost more for a reason. They have bigger market caps, between $300 million and $2 billion, meaning they're more financially stable than penny stocks, which typically have market caps below $300 million.

And Sid - whose recommendation from April 19 has given investors a 41.3% return since then - is recommending another top small-cap stock to buy in 2017. It's a biotech company with a strong track record of U.S. Food and Drug Administration (FDA) approval for its products. Three drugs were approved from 2010 to 2012, with one being the first of its kind sold over the counter and not requiring a doctor's prescription.

But even more impressive is this firm's incredible stretch of earnings beats. It's surpassed analyst expectations by an average of 57.6% in its last four quarterly earnings reports. According to Sid, that's a sign the big Wall Street banks underestimate the company's growth prospects, making now a great time to buy in before Wall Street catches on.

Here's our best small-cap stock to buy right now...

The Best Small-Cap Stock to Buy in 2017

Join the conversation. Click here to jump to comments…

Login
guest
guest
1 Comment
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
John
John
5 years ago

Hot penny stocks below $1

0
Reply
LIVE
Visit Money Morning Live


Latest News

March 29, 2023 • By Chris Johnson

Commercial Real Estate is Feeling the Aftershocks of the Financial Crisis

March 29, 2023 • By Kenny Glick

Here's How You Can Find a New Trade If You Just Missed Your Entry

March 29, 2023 • By Garrett Baldwin

It's Not You... It's the Market
Trending Stories
ABOUT MONEY MORNING

Money Morning gives you access to a team of market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

QUICK LINKS
About Us COVID-19 Announcements How Money Morning Works FAQs Contact Us Search Article Archive Forgot Username/Password Archives Profit Academy Research Your Team Videos Text Messaging Terms of Use
FREE NEWSLETTERS
Total Wealth Research Power Profit Trades Profit Takeover This Is VWAP Penny Hawk Trading Today Midday Momentum Pump Up the Close
PREMIUM SERVICES
Money Map Press Home Money Map Report Fast Fortune Club Weekly Cash Clock Night Trader Microcurrency Trader Hyperdrive Portfolio Rocket Wealth Initiative Extreme Profit Hunters Profit Revolution Warlock's World Quantum Data Profits Live Trading Alliance Trade The Close Inside Money Trader Expiration Trader Flashpoint Trader Darknet Hyper Momentum Trader Alpha Accelerators Weekly Profit Cycles Brutus Alerts

© 2023 Money Morning All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning.

Address: 1125 N Charles St. | Baltimore, MD, 21201 | USA | Phone: 888.384.8339 | Disclaimer | Sitemap | Privacy Policy | Whitelist Us | Do Not Sell or Share My Personal Information

wpDiscuz